Sangamo Therapeutics Inc (SGMO)
NASDAQ
Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 29.38M | 26.46M | 27.23M | 157.96M | 6.84M | 9.4M | 2.04M | 481k |
Operating Income | -45.73M | -54.89M | -55.39M | 38.47M | -123.57M | -61.61M | -67.1M | -47.18M |
Pre Tax Income | -43.09M | -53.13M | -51.71M | 21.33M | -120.77M | -102.89M | -60.57M | -48.99M |
Net Income | -43.17M | -53.16M | -51.97M | 21.13M | -114.51M | -104.16M | -60.3M | -49.09M |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | -45.73M | -54.89M | -55.39M | 38.47M | -123.57M | -61.61M | -67.1M | -47.18M |
EBITDA | -42.85M | -51.85M | -52.05M | 80.09M | -67.97M | -56.12M | -65.27M | -45.77M |
Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 19.39M | 36.57M | 84.45M | 102.43M | 118.19M | 110.7M | 111.3M | 176.23M |
Operating Income | -72.56M | -56.36M | -77.15M | -105.18M | -129.55M | -183.34M | -201.28M | -208.48M |
Pre Tax Income | -71.67M | -54.57M | -68.89M | -95.42M | -120.78M | -177.99M | -191.85M | -262.9M |
Net Income | -71.66M | -54.57M | -68.33M | -95.19M | -121M | -178.29M | -192.28M | -257.83M |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | -1.011 | -0.637 | -0.669 | -0.821 | -0.852 | -1.222 | -1.153 | -1.454 |
EBIT | -71.67M | -54.57M | -68.89M | -105.18M | -129.55M | -183.34M | -201.28M | -208.48M |
EBITDA | -71.56M | -54.86M | -74.79M | -101.25M | -123.87M | -173.9M | -189.17M | -103.93M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.